Peter Junker

6.4k citations
186 papers · 5.4k · h-index 39

Impact in

  • Rheumatology top 0.2%
    • Rheumatoid Arthritis Research and Therapies
    • Systemic Lupus Erythematosus Research
    • Spondyloarthritis Studies and Treatments
    • Osteoarthritis Treatment and Mechanisms
  • Immunology top 5%
    • Complement system in diseases

Papers in

  • Rheumatology 131
    • Rheumatoid Arthritis Research and Therapies 96
    • Systemic Lupus Erythematosus Research 21
    • Spondyloarthritis Studies and Treatments 10
  • Genetics 10
    • Myeloproliferative Neoplasms: Diagnosis and Treatment 9
Co-authors
Anne Voss (16 shared papers)Anders Jørgen Svendsen (22 shared papers)Kim Hørslev‐Petersen (52 shared papers)Mikkel Østergaard (48 shared papers)Merete Lund Hetland (50 shared papers)Kristian Stengaard‐Pedersen (45 shared papers)Hanne Lindegaard (25 shared papers)Helle Laustrup (8 shared papers)
Journals
Scandinavian Journal of Rheumatology (22 papers)Annals of the Rheumatic Diseases (20 papers)Arthritis Research & Therapy (8 papers)The Journal of Rheumatology (7 papers)Lupus (7 papers)
Partner nations
DenmarkSwedenUnited States

In The Last Decade

Peter Junker

183 papers receiving 5.2k citations

Peers

Peter Junker
Comparison fields: 5 of 126
  • Rheumatology 3.1k
  • Immunology 503
  • Genetics 160
  • Rehabilitation 90
  • Pathology and Forensic Medicine 192
Replace Imad W. Uthman with:
Imad W. Uthman Lebanon
Arnaud Constantin France
I. Lorenzen Denmark
María Galindo-Izquierdo Spain
Martin Fleck Germany
Geraldine Cambridge United Kingdom
Edward M J Vital United Kingdom
Olivier Vittecoq France
Mahboob U. Rahman United States
Peter Lamprecht Germany
Peter Junker relative to Imad W. Uthman Lebanon Imad W. Uthman's profile →
Citations per field
00.5×2×2.8×
Imad W. Uthman · 1×
Citations per year

Countries citing papers authored by Peter Junker

Since Specialization
Citations

This map shows the geographic impact of Peter Junker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Junker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Junker more than expected).

Fields of papers citing papers by Peter Junker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Junker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Junker. The network helps show where Peter Junker may publish in the future.

Co-authors

The 25 scholars most cited alongside Peter Junker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter Junker Line = papers co-authored together Peter Junker links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 186 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Functional variants in the B-cell gene BANK1 are associated with systemic lupus erythematosus
Nature Genetics ·Sergey V. Kozyrev, Anna-Karin Abelson, Jérôme Wojcik, Ammar Zaghlool, Mitsu Reddy, Elena Sánchez, Iva Gunnarsson, Elisabet Svenungsson
2008407
2
MRI bone oedema is the strongest predictor of subsequent radiographic progression in early rheumatoid arthritis. Results from a 2-year randomised controlled trial (CIMESTRA)
Annals of the Rheumatic Diseases ·Merete Lund Hetland, B Ejbjerg, Kim Hørslev‐Petersen, Søren Jacobsen, A Vestergaard, Anne Grethe Jurik, Kristian Stengaard‐Pedersen, Peter Junker
2008318
3
Radiographic progression and remission rates in early rheumatoid arthritis – MRI bone oedema and anti-CCP predicted radiographic progression in the 5-year extension of the double-blind randomised CIMESTRA trial
Annals of the Rheumatic Diseases ·Merete Lund Hetland, Kristian Stengaard‐Pedersen, Peter Junker, Mikkel Østergaard, B Ejbjerg, Søren Jacobsen, Tine Lottenburger, I. Hansen
2010168
4
Association of mannose-binding lectin gene variation with disease severity and infections in a population-based cohort of systemic lupus erythematosus patients
Genes and Immunity ·Peter Garred, Anne Voss, HO Madsen, Peter Junker
2001167
5
Combination treatment with methotrexate, cyclosporine, and intraarticular betamethasone compared with methotrexate and intraarticular betamethasone in early active rheumatoid arthritis: An investigator‐initiated, multicenter, randomized, double‐blind, parallel‐group, placebo‐controlled study
Arthritis & Rheumatism ·Merete Lund Hetland, Kristian Stengaard‐Pedersen, Peter Junker, Tine Lottenburger, Torkell Ellingsen, Lis Smedegaard Andersen, Ib Tønder Hansen, Henrik Skjødt
2006149
6
A multicentre study of 513 Danish patients with systemic lupus erythematosus. I. Disease manifestations and analyses of clinical subsets
Clinical Rheumatology ·Søren Jacobsen, Jørgen Holm Petersen, Susanne Ullman, Peter Junker, Anne Voss, Ulrik Tarp, Lone Hvitfeldt Poulsen, G. Hansen
1998134
7
HLA‐G genotype and HLA‐G expression in systemic lupus erythematosus: HLA‐G as a putative susceptibility gene in systemic lupus erythematosus
Tissue Antigens ·Roberta Rizzo, Thomas Vauvert F. Hviid, Marcello Govoni, Melissa Padovan J J, Michele Rubini, Loredana Melchiorri, Marina Stignani, Sabrina Carturan
2008116
8
YKL‐40, a Matrix Protein of Specific Granules in Neutrophils, Is Elevated in Serum of Patients with Community‐Acquired Pneumonia Requiring Hospitalization
The Journal of Infectious Diseases ·Claudia Maria Nordenbæk, Julia S. Johansen, Peter Junker, Niels Borregaard, Ole E. Sørensen, Paul A. Price
1999112
9
Surfactant protein D (SP-D) serum levels in patients with community-acquired pneumonia
Clinical Immunology ·Rikke Leth‐Larsen, Claudia Maria Nordenbæk, Ida Tornøe, Vivi Moeller, Anders Grønnegaard Schlosser, Claus Koch, Boerge Teisner, Peter Junker
2003107
10
Adalimumab added to a treat-to-target strategy with methotrexate and intra-articular triamcinolone in early rheumatoid arthritis increased remission rates, function and quality of life. The OPERA Study: an investigator-initiated, randomised, double-blind, parallel-group, placebo-controlled trial
Annals of the Rheumatic Diseases ·Kim Hørslev‐Petersen, Merete Lund Hetland, Peter Junker, Jan Pødenphant, Torkell Ellingsen, Palle Ahlquist, Hanne Lindegaard, Asta Linauskas
2013105
11
Aggressive combination therapy with intra-articular glucocorticoid injections and conventional disease-modifying anti-rheumatic drugs in early rheumatoid arthritis: second-year clinical and radiographic results from the CIMESTRA study
Annals of the Rheumatic Diseases ·Merete Lund Hetland, Kristian Stengaard‐Pedersen, Peter Junker, Tine Lottenburger, I. Hansen, Lis Smedegaard Andersen, Ulrik Tarp, Anders Jørgen Svendsen
2007102
12
A multicentre study of 513 Danish patients with systemic lupus erythematosus. II. Disease mortality and clinical factors of prognostic value
Clinical Rheumatology ·Søren Jacobsen, Jørgen Holm Petersen, Susanne Ullman, Peter Junker, Anne Voss, Ulrik Tarp, Lone Hvitfeldt Poulsen, G. Hansen
1998100
13
Structural insertion/deletion variation in IRF5 is associated with a risk haplotype and defines the precise IRF5 isoforms expressed in systemic lupus erythematosus
Arthritis & Rheumatism ·Sergey V. Kozyrev, Susanna Lewén, Prasad M. V. Linga Reddy, Bernardo Antonio Pons‐Estel, Torsten Witte, Peter Junker, Helle Laustrup, Carmen Gutiérrez
200799
14
Ankylosing spondylitis in Danish and Norwegian twins: occurrence and the relative importance of genetic vs. environmental effectors in disease causation
Scandinavian Journal of Rheumatology ·Ole Birger Pedersen, Anders Jørgen Svendsen, L. Ejstrup, Axel Skytthe, Peter Junker +1 other
200884
15
Relative importance of genetic effects in rheumatoid arthritis: historical cohort study of Danish nationwide twin population.
PubMed ·Anders Jørgen Svendsen, Niels Vilstrup Holm, Kirsten Ohm Kyvik, Per Hyltoft Petersen, Peter Junker
200281
16
Complement receptor expression and activation of the complement cascade on B lymphocytes from patients with systemic lupus erythematosus (SLE)
Clinical & Experimental Immunology ·Hanne Vibeke Hansen Marquart, Anders Jørgen Svendsen, Claus Henrik Nielsen, Peter Junker, Sven‐Eric Svehag, Robert G. Q. Leslie +1 other
199574
17
Short- and long-term efficacy of intra-articular injections with betamethasone as part of a treat-to-target strategy in early rheumatoid arthritis: impact of joint area, repeated injections, MRI findings, anti-CCP, IgM-RF and CRP
Annals of the Rheumatic Diseases ·Merete Lund Hetland, Mikkel Østergaard, Bo Ejbjerg, Søren Jacobsen, Kristian Stengaard‐Pedersen, Peter Junker, Tine Lottenburger, Ib Tønder Hansen
201272
18
On the Origin of Rheumatoid Arthritis: The Impact of Environment and Genes—A Population Based Twin Study
PLoS ONE ·Anders Jørgen Svendsen, Kirsten Ohm Kyvik, Gunnar Houen, Peter Junker, Kaare Christensen, Lene Christiansen, Christian Nielsen, Axel Skytthe
201370
19
CXCL13 predicts disease activity in early rheumatoid arthritis and could be an indicator of the therapeutic `window of opportunity'
Arthritis Research & Therapy ·Stinne Ravn Greisen, Karen Kræmmer Schelde, Tue Kruse Rasmussen, Tue Wenzel Kragstrup, Kristian Stengaard‐Pedersen, Merete Lund Hetland, Kim Hørslev‐Petersen, Peter Junker
201469
20
On the heritability of psoriatic arthritis. Disease concordance among monozygotic and dizygotic twins
Annals of the Rheumatic Diseases ·Ole Birger Pedersen, Anders Jørgen Svendsen, L. Ejstrup, Axel Skytthe, Peter Junker
200865

About Peter Junker

Peter Junker is a scholar working on Rheumatology, Genetics, Pathology and Forensic Medicine, Rehabilitation and Cell Biology, having authored 186 papers that have together received 5.4k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (96 papers), Systemic Lupus Erythematosus Research (21 papers), Spondyloarthritis Studies and Treatments (10 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (9 papers), Wound Healing and Treatments (6 papers), Vitamin D Research Studies (5 papers), Biomarkers in Disease Mechanisms (5 papers) and Proteoglycans and glycosaminoglycans research (5 papers). The work is most often cited by research in Rheumatology (3.1k citations), Immunology (503 citations), Genetics (160 citations), Rehabilitation (90 citations) and Pathology and Forensic Medicine (192 citations). Peter Junker has collaborated with scholars based in Denmark, Sweden and United States. Frequent co-authors include Anne Voss, Anders Jørgen Svendsen, Kim Hørslev‐Petersen, Mikkel Østergaard, Merete Lund Hetland, Kristian Stengaard‐Pedersen, Hanne Lindegaard, Helle Laustrup, I. Lorenzen and Hans Carl Hasselbalch. Their work appears in journals such as Scandinavian Journal of Rheumatology, Annals of the Rheumatic Diseases, Arthritis Research & Therapy, The Journal of Rheumatology and Lupus.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Imad W. UthmanBreakdown of academic impact, for papers by Arnaud ConstantinBreakdown of academic impact, for papers by I. LorenzenBreakdown of academic impact, for papers by María Galindo-IzquierdoBreakdown of academic impact, for papers by Martin FleckBreakdown of academic impact, for papers by Geraldine CambridgeBreakdown of academic impact, for papers by Edward M J VitalBreakdown of academic impact, for papers by Olivier VittecoqBreakdown of academic impact, for papers by Mahboob U. RahmanBreakdown of academic impact, for papers by Peter Lamprecht